论文部分内容阅读
目的:分析探讨依达拉奉注射液治疗急性脑梗死的临床疗效。方法:将60例急性脑梗死患者随机分成两组进行对照分析。对照组30例患者进行常规性治疗,实验组30例患者在常规性治疗的基础上给予依达拉奉注射液,通过两组的实验数据比较分析实验组与对照组的治疗效果。结果:实验组患者的治疗效果优于对照组患者,且P<0.05。结论:依达拉奉注射液治疗急性脑梗死效果显著,并且无明显的毒副作用。
Objective: To analyze the clinical efficacy of edaravone injection in the treatment of acute cerebral infarction. Methods: Sixty patients with acute cerebral infarction were randomly divided into two groups for comparative analysis. Thirty patients in the control group were treated routinely. Thirty patients in the experimental group were given edaravone injection on the basis of routine treatment. The therapeutic effects of the experimental group and the control group were compared by the experimental data of two groups. Results: The treatment effect of the experimental group was better than that of the control group, P <0.05. Conclusion: Edaravone injection is effective in treating acute cerebral infarction with no obvious side effects.